|
|
|
|
Chronic Lymphocytic Leukemia
SuperGen Reports Results From Combination Study In CLL Published ... 14 Mar 2006
Trading Markets, ...a three-drug combination therapy of pentostatin, cyclophosphamide and rituximab for previously treated patients with Chronic Lymphocytic Leukemia or other low ...
SuperGen Announces Results From Combination Study in CLL Published ... 14 Mar 2006
DG News Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia," appearing in the April ...
Genta Announces Closing of Common Stock Offering 14 Mar 2006
Yahoo! News (press release) ...for the use of Genasense plus fludarabine and cyclophosphamide for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). ...
Pentostatin, Cyclophosphamide, Rituxan® Active in Chronic ... Mar 10, 2006
Cancer Consultants (press release), Cytoxan®), and the biologic agent Rituxan® (rituximab) appears promising for patients with recurrent or progressive chronic lymphocytic leukemia. ...
Some Chronic Leukemia Patients May Improve by Taking an Extract of ... Mar 7, 2006
eMaxHealth.com, ...provides preliminary evidence to suggest a component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia (CLL). ...
Blood cancer survivor shares her experiences, goals Mar 13, 2006
San Mateo County Times, Q. Why did you get involved with the Leukemia Society? A. I was diagnosed with a form of leukemia, chronic lymphocytic leukemia, CLL, four years ago. ...
Natco Pharma launches 'Lymfuda' for Lymphocytic Leukemia Mar 7, 2006
NewKerala.com, Mumbai: Natco Pharma Ltd today launched its brand 'Lymfuda' 10 mg tablet used in the treatment of chronic lymphocytic leukemia (CLL). ...
Genta Incorporated Announces Fourth Quarter and Year End 2005 ... Mar 10, 2006
PR Newswire (press release), New Drug Application (NDA) for Genasense(R) (oblimersen sodium) Injection plus chemotherapy for the treatment of patients with chronic lymphocytic leukemia (CLL ...
FDA to review Genta drug in leukemia indication Mar 2, 2006
Pharmaceutical Business Review By Staff Writer. The FDA has accepted Genta Incorporated's new drug application for Genasense to be used in the treatment of chronic lymphocytic leukemia. ...
Genitope Initiates MyVax Leukemia Trial Feb 28, 2006
International News Service, ...developer Genitope has initiated a clinical trial to evaluate the use of MyVax personalized immunotherapy in the treatment of chronic lymphocytic leukemia. ...
Keryx commences phase II trial in leukemia Mar 3, 2006
Pharmaceutical Business Review ...perifosine) as a single agent in relapsed or refractory acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), high ...
Genta leukemia drug accepted for review Mar 1, 2006
United Press International WASHINGTON, March 1 (UPI) -- Genta said Wednesday its application for Genasense to treat chronic lymphocytic leukemia has been accepted for review. ...
BioCryst Initiates Intravenous Peramivir Phase I Clinical Trial Mar 9, 2006
International News Service, ...being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL), a Phase II trial in chronic lymphocytic leukemia (CLL) and a ...
Genasense(R) New Drug Application Accepted for Review by FDA Mar 1, 2006
PR Newswire (press release), NDA Proposes Use of Genasense plus Chemotherapy for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia BERKELEY HEIGHTS, NJ, March 1 /PRNewswire ...
Vion Reports 2005 Year-End and Fourth Quarter Financial Results Mar 10, 2006
Webbolt Business News (subscription), ...myelogenous leukemia and high-risk myelodysplastic syndrome, adult and pediatric brain tumors, small cell lung cancer and chronic lymphocytic leukemia, and in ...
XOMA Reports 2005 Results; Significant Revenue Growth and Other ... Mar 8, 2006
Genetic Engineering News, HHSN266200500004C. -- In April of 2005, we announced the initiation of a Phase I study for patients with advanced chronic lymphocytic leukemia under our ...
Genitope Corporation Initiates Clinical Trial to Evaluate MyVax(R) ... Feb 27, 2006
PR Newswire (press release), ...today announced the initiation of a clinical trial to evaluate the use of MyVax(R) personalized immunotherapy to treat Chronic Lymphocytic Leukemia (CLL), a ...
Genta Posts Q4 Loss On Lower Revenues - Update Mar 10, 2006
Trading Markets, ...of a collaborative agreement in May 2005 with sanofi-aventis to commercialize Genasense for the treatment of patients with chronic lymphocytic leukemia or CLL. ...
Keryx Biopharmaceuticals, Inc. Commences Phase 2, Multi-Center ... Mar 2, 2006
PharmaLive.com (press release), ...perifosine as a single agent in relapsed or refractory acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), high ...
Genitope leukemia drug on track Feb 27, 2006
United Press International REDWOOD CITY, Calif., Feb. 27 (UPI) -- Genitope said Monday it initiated a phase 1/2 trial of MyVax, a personalized vaccine for chronic lymphocytic leukemia. ...
Students help raise money for leukemia research Mar 2, 2006
Sapulpa Daily Herald, ...and spleen. The four major types of leukemia are acute or chronic myelogenous and acute or chronic lymphocytic leukemia. The children ...
Treatment Response Linked with Symptom Improvement in CLL Feb 22, 2006
Cancer Consultants (press release), Genasense® (oblimersen sodium) to chemotherapy increased the likelihood of remission in patients with relapsed or refractory chronic lymphocytic leukemia (CLL ...
XOMA Reports 2005 Results; Significant Revenue Growth and Other ... Mar 8, 2006
International News Service, ...cells. In April of 2005, we announced the initiation of Phase I study for patients with advance chronic lymphocytic leukemia ("CLL"). ...
Genta to have Genasense decision by fall Mar 1, 2006
BusinessWeek The company said the FDA accepted its marketing application for Genasense to treat chronic lymphocytic leukemia in conjunction with two chemotherapy drugs ...
Does green tea fight cancer? Mar 2, 2006
myDNA.com, 2005, the Mayo Clinic in Rochester, Minn., released a case study suggesting green tea improved the conditions of four people with chronic lymphocytic leukemia. ...
FDA accepts Genta's application Mar 1, 2006
MarketWatch ..., , ) said the FDA will review its application seeking approval of Genasense as a treatment for patients with chronic lymphocytic leukemia who have relapsed. ...
Point Therapeutics to Host Fourth Quarter and Fiscal Year 2005 ... Mar 7, 2006
Genetic Engineering News, ...in metastatic melanoma, in combination with cisplatin in metastatic melanoma, in combination with rituximab in advanced chronic lymphocytic leukemia, and in ...
MicroRNA Profiling Arrays Mar 8, 2006
Bioscience Technology, ...between tissues and developmental stages, and several miRNAs appear to be down-regulated in patients with chronic lymphocytic leukemia, colonic adenocarcinoma ...
Genta leukemia drug shows efficacy in late stage trial Feb 17, 2006
Pharmaceutical Business Review Genta's phase III trial evaluating its drug Genasense in combination with chemotherapy in patients with chronic lymphocytic leukemia has produced positive data ...
Cyclophosphamide Aids Fludarabine Against Leukemia Feb 18, 2006
Cancerpage.com, ...results in greater response rates and longer treatment- and progression-free survival in younger patients with chronic lymphocytic leukemia (CLL), German ...
Infinity Announces Major Drug Discovery, Development and ... Mar 6, 2006
PR Newswire (press release), ...agents in B cell malignancies that are dependent on Bcl-2 family members for their survival (eg, follicular lymphoma, chronic lymphocytic leukemia and diffuse ...
Clinical Benefit Analysis of Genasense plus Chemotherapy Reported ... Feb 15, 2006
PharmaLive.com (press release), Phase 3 trial of chemotherapy with or without Genasense (oblimersen sodium) Injection in patients with relapsed or refractory chronic lymphocytic leukemia (CLL ...
Genzyme Reports Financial Results for Fourth Quarter of 2005 and ... Feb 15, 2006
MSN Money This Phase 3 study evaluated the use of Campath(R) (alemtuzumab for injection) as a first-line therapy for patients with B- cell chronic lymphocytic leukemia. ...
Geron Corporation Reports Fourth Quarter and Annual 2005 Financial ... Feb 28, 2006
Genetic Engineering News, ...granted clearance to initiate clinical testing of Geron's telomerase inhibitor anti-cancer compound, GRN163L, in patients with chronic lymphocytic leukemia (CLL ...
Bioenvision to Host Conference Call Following Positive Opinion of ... Feb 23, 2006
Genetic Engineering News, In addition, clofarabine is in clinical development for the treatment of myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid ...
Clinical Trials Update: Feb. 15, 2006 Feb 15, 2006
Forbes ...is to see if the combination of thalidomide with fludarabine is safe and effective in the treatment of patients with untreated chronic lymphocytic leukemia. ...
Today's Early Winners and Losers Mar 1, 2006
TheStreet.com ...which has had a rocky history, along with fludarabine and cyclophosphamide for treating patients with relapsed or refractory chronic lymphocytic leukemia. ...
Geron Licenses MaxCyte Cell Loading Technology for Use in Closed ... Feb 15, 2006
International News Service, ...three drug candidates in collaboration with leading researchers: one in Phase I/II clinical trials for treatment of chronic lymphocytic leukemia and two ...
Genzyme Reports Financial Results for Fourth Quarter of 2005 and ... Feb 15, 2006
WebWire (press release), This Phase 3 study evaluated the use of Campath® (alemtuzumab for injection) as a first-line therapy for patients with B-cell chronic lymphocytic leukemia. ...
Harper’s Findings Mar 5, 2006
Arkansas Democrat-Gazette (subscription), ...that milk-thistle extract does not help patients with liver disease, though green-tea extract does appear to help people with chronic lymphocytic leukemia. ...
Founder of Stein drugstores, Stein Optical dies of cancer Mar 4, 2006
Chippewa Herald, ...has died of cancer. He was 68. Stein was diagnosed with chronic lymphocytic leukemia in 1994. He died Thursday. Stein, a former ...
FDA accepts Genta's application for Genasense injection Mar 1, 2006
Reuters ...said the application proposes the use of Genasense and chemotherapy for the treatment of patients with relapses or refractory chronic lymphocytic leukemia. ...
Bioenvision Readies For EU Review Of Clofarabine Feb 15, 2006
Forbes ...on lower penetration assumptions--due to a later than expected launch--in adult AML [acute myeloid leukemia] and chronic lymphocytic leukemia (CLL)," wrote FBR ...
Highlights of rising and falling US stocks Mar 1, 2006
Investor's Business Daily (subscription) ...for its Genasense injection to be used in conjunction with chemotherapy to treat patients with relapsed or refractory chronic lymphocytic leukemia was accepted ...
He helped others clearly see humanity Mar 2, 2006
Milwaukee Journal Sentinel (subscription), Martin F. Stein died of cancer Thursday at his home downtown. He was 68. Stein was diagnosed with chronic lymphocytic leukemia in 1994. ...
European Regulatory Committee Recommends Orphan Drug Status for ... Feb 14, 2006
Market Wire (press release) 1D09C3 was previously granted orphan medicinal product designation by the European Commission for Hodgkin's lymphoma and chronic lymphocytic leukemia, a type ...
NJ company to make Geron vaccine Feb 14, 2006
San Jose Business Journal, ...therapies to treat chronic diseases. Its other anti-cancer product, also in Phase 1-2 trials, treats chronic lymphocytic leukemia.
http://www.cambrex.com Feb 13, 2006
Genetic Engineering News, ...target telomerase: GRN163L, a potent and specific telomerase inhibitor drug that is in a Phase 1-2 clinical trial in chronic lymphocytic leukemia (CLL); and ...
Drug stocks reverse course to finish higher Feb 15, 2006
MarketWatch ...said a Phase III clinical trial for its oncology drug Genasense showed that it helped prevent patients suffering from chronic lymphocytic leukemia, or CLL ...
GPC Biotech's anticancer drug 1D09C3 recommended for 'orphan drug' ... Feb 14, 2006
Forbes The drug was previously granted orphan medicinal product designation by the European Commission for Hodgkin's lymphoma and chronic lymphocytic leukemia, a type ...
Vaccine-making contract goes to Cambrex Feb 24, 2006
In-PharmaTechnologist.com, ...clinic that target telomerase: GRN163L, a specific telomerase inhibitor drug that is in a Phase I-II clinical trial in chronic lymphocytic leukemia (CLL); and ...
Hearings resume tonight in Agent Orange inquiry Feb 13, 2006
CTV.ca, Department has cited a US study that says there is "Sufficient evidence of an association," between Agent Orange and chronic lymphocytic leukemia, soft-tissue ...
p53 and the sea Feb 11, 2006
Scientist, ...of the work his group has done in elucidating the relationship between specific micro RNA expression signatures and prognosis in chronic lymphocytic leukemia. ...
Humor is good medicine for Mom, no matter the prognosis Feb 23, 2006
Anchorage Daily News, York. I have a feeling I'll be back East again several times in the next year. My mother has chronic lymphocytic leukemia. She tells ...
Taking a stride against cancer Feb 12, 2006
Fitchburg Sentinel, Feldman's name. Physicians diagnosed Feldman, 61, with chronic lymphocytic leukemia in April 2000, he said Wednesday. He almost ...
Biopharmaceutical Industry Leader Joins Acologix, Inc. Board of ... Feb 15, 2006
PharmaLive.com (press release), Berlex, Mr. Robin was responsible for the clinical development and commercialization of drugs such as Fludara(R) for chronic lymphocytic leukemia and Betaseron ...
Highlights of rising and falling US stocks Feb 15, 2006
Investor's Business Daily (subscription) III trial of its Genasense oncology injection used in conjunction with chemotherapy to treat patients with relapsed or refractory chronic lymphocytic leukemia. ...
Revlimid® Has Significant Activity in Chronic Lymphocytic ... 25 Jan 2006
Cancer Consultants (press release), ...and the Toronto Sunnybrook Regional Cancer Center have reported that Revlimid (lenalidomide) has significant activity in chronic lymphocytic leukemia (CLL). ...
MaxCyte To Be Sponsor and Featured Speaker at the Phacilitate Cell ... 25 Jan 2006
PR Newswire (press release), ...system for non- viral gene delivery in the clinical development of an engineered tumor vaccine product for treatment of B-cell Chronic Lymphocytic Leukemia. ...
Treandaâ„¢ Has Significant Activity in Treatment of Recurrent NHL 25 Jan 2006
Cancer Consultants (press release), Treanda has been marketed and used clinically in Germany for many years in patients with NHL, chronic lymphocytic leukemia (CLL), multiple myeloma, breast ...
BiovaxID Yields 89% Survival in Patients with Aggressive Non ... 25 Jan 2006
DG News B-cell lymphocytes can undergo malignant transformation to become Non-Hogkin's lymphoma, multiple myeloma or chronic lymphocytic leukemia. ...
Genetic Features Predict Response of Chronic Lymphocytic Leukemia ... Jan 20, 2006
Cancer Consultants (press release), ...published in the Journal of Clinical Oncology, specific genetic features may help predict outcomes among patients with chronic lymphocytic leukemia who are ...
Revlimid, as oral treatment regimen in chronic lymphocytic ... Jan 19, 2006
Xagena.it, The clinical data from a Revlimid study in Chronic Lymphocytic Leukemia ( CLL ) were reported at an oral presentation during the 47th American Society of ...
Immunochemotherapy Improves Outcome in Chronic Lymphocytic ... Jan 17, 2006
Cancerpage.com, ...to the chemotherapeutic agent fludarabine is associated with improved clinical outcome in patients with untreated chronic lymphocytic leukemia (CLL), suggest ...
Vion Pharmaceuticals Receives Orphan Drug Designation for ... Jan 23, 2006
DG News ...myelogenous leukemia and high-risk myelodysplastic syndrome, adult and pediatric brain tumors, small cell lung cancer and chronic lymphocytic leukemia, and in ...
Chronic lymphocytic leukaemia: benefit of green tea Jan 14, 2006
Xagena.it, ...provides preliminary evidence to suggest a component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia ( CLL). ...
Rituxan® Plus GM-CSF Safe and Effective for Chronic Lymphocytic ... Jan 12, 2006
Cancer Consultants (press release), ...factor, Leukine®, (sargramostim) is well tolerated and very effective for previously untreated or treated patients with chronic lymphocytic leukemia (CLL). ...
Mayo Clinic believes green tea may benefit leukemia patients Jan 16, 2006
Newstarget.com, According to research conducted at the Mayo Clinic, patients with chronic lymphocytic leukemia (CLL) may demonstrate improvement with regular consumption of ...
North Shore-LIJ renames Glen Cove Hospital Jan 23, 2006
Long Island Business News (subscription), Chiorazzi, a scientist specializing in chronic lymphocytic leukemia, last year said that he would step down to concentrate on research. ...
BioCryst Receives FDA Fast Track Designation for Peramivir Jan 17, 2006
Biotech Intelligence (press release), ...being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL), a Phase II trial in chronic lymphocytic leukemia (CLL) and a ...
Alarm frontman diagnosed with leukemia Dec 29, 2005
RTE.ie, The Alarm frontman Mike Peters has been diagnosed with Chronic Lymphocytic Leukemia (CLL), a treatable, although non-curable, form of cancer. ...
Seahawks fans have eyes set on Super Bowl Jan 21, 2006
The Olympian, Diagnosed with chronic lymphocytic leukemia seven years ago, Vandiver was told that on average, patients die within eight to 12 years. ...
Autoimmune Diseases Linked with Specific Subtypes of Non-Hodgkin ... Jan 10, 2006
Cancer Consultants (press release), The subtypes of NHL in the cases were diffuse large B-cell (796 subjects); chronic lymphocytic leukemia/small lymphocytic lymphoma (752 subjects); follicular ...
HuMax®-CD20 Safe and Effective Treatment for Relapsed/Refractory ... Jan 10, 2006
Cancer Consultants (press release), ASH), the targeted agent HuMax®-CD20, which is still in clinical trials, provides anticancer activity in patients with chronic lymphocytic leukemia (CLL) who ...
Genta Files New Drug Application for FDA Approval of Genasense(R) ... Dec 29, 2005
PR Newswire (press release), ...proposes the use of Genasense plus fludarabine and cyclophosphamide as treatment for patients with relapsed or refractory chronic lymphocytic leukemia (CLL). ...
Meghan Fitzgerald Joins Vion's Senior Management Team Jan 10, 2006
PR Newswire (press release), ...myelogenous leukemia and high-risk myelodysplastic syndromes, adult and pediatric brain tumors, small cell lung cancer and chronic lymphocytic leukemia, and in ...
HuMax®-CD20 Safe and Effective Treatment for Relapsed/Refractory ... Jan 11, 2006
Cancer Consultants (press release), HuMax CD20 fully human monoclonal antibody in chronic lymphocytic leukemia: early results from an ongoing phase I/II clinical trial. Blood. ...
Small Molecule Bcl-2 Protein Inhibitor, GX15-070, Active for ... Jan 12, 2006
Cancer Consultants (press release), ...molecule pan-Bcl-2 family inhibitor GX15-070 administered intravenously (IV) every 3 weeks to patients with previously treated chronic lymphocytic leukemia. ...
Point Therapeutics To Host Webcast On January 31, 2006 Webcast To ... Jan 20, 2006
Genetic Engineering News, ...in metastatic melanoma, in combination with cisplatin in metastatic melanoma, in combination with rituximab in advanced chronic lymphocytic leukemia, and in ...
Staff rallies around ill Tumwater police chief Jan 14, 2006
The Olympian, He was diagnosed seven years ago with a blood and bone disease called chronic lymphocytic leukemia, which tends to worsen over time. ...
Alarm Frontman Fights Cancer Dec 27, 2005
Billboard, Mike Peters has begun chemotherapy treatments for Chronic Lymphocytic Leukemia (CLL). The Alarm frontman was diagnosed earlier this ...
Doctor: Jailed priest has developed leukemia Dec 29, 2005
Miami Herald, Dr. Paul Farmer, a friend and supporter of Jean-Juste, says the jailed priest has chronic lymphocytic leukemia (CLL), a form of the blood and marrow disease ...
Mike Peters of The Alarm has Leukemia Dec 28, 2005
6abc.com, ...diagnosed with leukemia. He writes on The Alarm's web site he was diagnosed December 8th with chronic lymphocytic leukemia. Peters says ...
Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue Jan 9, 2006
MSN Money Campath is approved for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have ...
GX15-070 Active in Refractory CLL Jan 10, 2006
Cancer Consultants (press release), ...of Hematology (ASH), the agent GX15-070, which is still in clinical trials, has anticancer activity in patients with chronic lymphocytic leukemia (CLL) who ...
Alarm frontman fights cancer Dec 28, 2005
Monsters and Critics.com, By Barry a. Jeckell Dec 28, 2005, 12:42 GMT. Mike Peters has begun chemotherapy treatments for Chronic Lymphocytic Leukemia (CLL). ...
Haiti's Death by Democracy: The Slow Demise of Father Gerry Jan 3, 2006
PEJ News, The tests came back last week, and show that Fr. Gerry has chronic lymphocytic leukemia. ... Jean-Juste with chronic lymphocytic leukemia. ...
BioCryst Initiates Intravenous Phase I/II Clinical Trial of ... Dec 22, 2005
PR Newswire (press release), ...and has been designated an "Orphan Drug" for broader indications, including cutaneous T-cell lymphoma (CTCL), chronic lymphocytic leukemia (CLL) and acute ...
ZymoGenetics Reports Preliminary Positive Results From TACI-Ig ... Jan 10, 2006
PR Newswire (press release), ...with SLE, rheumatoid arthritis and advanced B-cell malignancies, such as multiple myeloma, B-cell non-Hodgkin's lymphoma and chronic lymphocytic leukemia. ...
Bittersweet organ music at Trinity Lutheran Jan 9, 2006
Wisconsin State Journal, Fuerst, who is combating chronic lymphocytic leukemia, will continue to serve frequently as organist, but will no longer be a full-time musician and will no ...
A War's Unwelcome Vestiges Jan 17, 2006
TheDay (subscription), Non-Hodgkin's lymphoma is on the VA's list, as is chronic lymphocytic leukemia, multiple myeloma, Hodgkin's disease, respiratory cancers, prostate cancer, soft ...
Solidarity nourishes hope in Haiti's prisons Jan 16, 2006
Bay Area Indymedia, Several weeks ago, Father Jean Juste was diagnosed with chronic lymphocytic leukemia (CLL) by Dr. Paul Farmer of Harvard, a friend and physician who has been ...
Genzyme names new head of product development for Campath Jan 12, 2006
San Antonio Business Journal, Campath, the only monoclonal antibody approved by the Food and Drug Administration for the treatment of patients with B-cell chronic lymphocytic leukemia. ...
'Prisoner of conscience' faces a deadly illness Jan 2, 2006
Miami Herald, ...that the Rev. Jean-Juste has developed chronic lymphocytic leukemia, a cancer that could develop into a more-virulent strain. If he ...
Kanti R. Rai becomes president of the ASH Jan 5, 2006
Baldwin Herald Research, based in Manhasset, Rai is known around the world for establishing the Rai clinical staging system for chronic lymphocytic leukemia, which helps ...
Green Tea Extract May Fight Leukemia Dec 23, 2005
Forbes 23 (HealthDay News) -- A green tea extract called epigallocatechin gallate (EGCG) may benefit people with chronic lymphocytic leukemia (CLL), according to ...
Leukemia Patients May Benefit From Green Tea Dec 22, 2005
All Headline News ...team from the Mayo Clinic. The tea seems to make a difference in patients with chronic lymphocytic leukemia (CLL). CLL is a blood ...
Mike Peters fighting Cancer Dec 22, 2005
antiMUSIC.com, Last Thursday on the 8th December, I was diagnosed as having cancer. I have been told by my consultant, Dr. E that I have Chronic Lymphocytic Leukemia (CLL). ...
Contributed by: Anonymous Jan 5, 2006
Infoshop News Gerard Jean-Juste, the Haitian priest who has been imprisoned in Haiti since his illegal arrest on July 21 has been diagnosed with chronic lymphocytic leukemia ...
SIXTH ANNUAL REPORT: FUTURE BLOCKBUSTERS Dec 30, 2005
Med Ad News (subscription), Revlimid for a broad range of hematology and oncology conditions, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia, as well ...
Genta completes filing with FDA for cancer drug Dec 29, 2005
Reuters Research) said on Thursday that it has submitted a full application for approval to sell its cancer drug Genasense to treat chronic lymphocytic leukemia. ...
Genta Shares Climb on FDA Application Dec 29, 2005
MSN Money ...or oblimersen sodium, plus fludarabine and cyclophosphamide be used as treatment for patients with relapsed or refractory chronic lymphocytic leukemia. ...
Genta Files for Genasense OK in Europe Jan 3, 2006
MSN Money Food and Drug Administration Dec. 29 for the drug to treat chronic lymphocytic leukemia, a cancer that attacks white blood cells.
FDA approves REVLIMID for MDS Dec 29, 2005
Cancerfacts.com, Celgene is also testing REVLIMID for treatment of multiple myeloma, chronic lymphocytic leukemia, and certain solid tumor cancers.
Garden State Business Briefs Dec 29, 2005
Newark Star Ledger, ...proposes the use of Genasense plus fludarabine and cyclophosphamide as treatment for patients with relapsed or refractory chronic lymphocytic leukemia. ...
Alarm Singer Diagnosed with Cancer Dec 28, 2005
Aversion The singer revealed the diagnosis on the band’s web site earlier this week, saying he’s been diagnosed with chronic lymphocytic leukemia (CLL), a form of ...
(PRN) - Lubrizol Sells Engine Control Systems Business ... [+] Dec 29, 2005
Bolsamania.com, Genta Files New Drug Application for FDA Approval of Genasense(R) Plus Chemotherapy for Patients with Advanced or Refractory Chronic Lymphocytic Leukemia ... ...
Power line plan sparks ire Dec 28, 2005
Portage Daily Register, ...chronic lymphocytic leukemia associated with occupational exposure," according to a 1999 report by the National Institute of Environmental Health Sciences.
Genta Completes Marketing Authorization Application to EMEA for ... Jan 3, 2006
Yahoo! News (press release) ...a new drug application (NDA) to the US FDA for the use of Genasense plus chemotherapy in patients with relapsed or refractory chronic lymphocytic leukemia. ...
After Adding $25M, Novacea To Launch DN-101 Phase III Jan 4, 2006
BioWorld Online (subscription), ...clinical product, banoxantrone (AQ4N), is in Phase I and Phase I/II trials for advanced solid tumors, non-Hodgkin's lymphoma and chronic lymphocytic leukemia. ...
Music Notes Dec 28, 2005
Richmond Times Dispatch, Mike Peters of The Alarm has started treatment for chronic lymphocytic leukemia, with which he was diagnosed earlier this month. ...
Inland Southern California Dec 30, 2005
Press-Enterprise (subscription), ...public offering in early May. Mike Peters has begun chemotherapy treatments for chronic lymphocytic leukemia. The Alarm frontman was ...
Role Of MicroRNA Identified In Thyroid Cancer Dec 23, 2005
Science Daily (press release) Treat It (September 18, 2005) -- A new and unusual class of genes plays an important role in the development of chronic lymphocytic leukemia (CLL), according ...
Early hope seen for green tea in fighting leukemia 21 Dec 2005
Reuters The patients all had chronic lymphocytic leukemia, or CLL, a form of leukemia that usually arises during or after middle-age and typically progresses slowly. ...
Roswell Park Research Presented at National Hematology Meeting 21 Dec 2005
Newswise (press release) ...of Medicine, is the principal investigator of the first study to report clinical activity of lenalidomide in patients with chronic lymphocytic leukemia (CLL). ...
Chronic leukemia patients may benefit by green tea extracts Dec 14, 2005
Newindpress, WASHINGTON: A component of green tea may lead to clinical improvement in patients with Chronic Lymphocytic Leukemia (CLL), according to a new study published ...
REVLIMID Clinical Results as Oral Treatment Regimen in Chronic ... Dec 12, 2005
PharmaLive.com (press release), 12 /PRNewswire-FirstCall/ -- Celgene Corporation announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were reported at an ...
Mayo Clinic Reports Some Chronic Leukemia Patients May Improve By ... Dec 14, 2005
Science Daily (press release) ...provides preliminary evidence to suggest a component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia (CLL). ...
Chronic leukemia patients may benefit by green tea extracts Dec 14, 2005
Webindia123, A component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia (CLL), according to a new study published in Leukemia ...
Pharmacyclics' Stock Crushed After Failed Phase III Of Xcytrin Dec 19, 2005
BioWorld Online (subscription), ...non-Hodgkin's lymphoma; Phase II results demonstrated single-agent activity in refractory low-grade lymphoma and chronic lymphocytic leukemia; and preclinical ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in Chronic ... Dec 12, 2005
Yahoo! News (press release) FirstCall/ -- Celgene Corporation (Nasdaq: CELG - News) announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were reported ...
Seattle Genetics Expands SGN-40 Clinical Program into Chronic ... Nov 29, 2005
Business Wire (press release), ...(Nasdaq:SGEN) announced today that it has initiated a phase I/II clinical trial of SGN-40 in patients with chronic lymphocytic leukemia (CLL). ...
Green tea helps leukemia -- study Dec 14, 2005
United Press International
| |
